Key Points: COVID In today’s Recommendation for Industry, we discuss what it means to be up to date in COVID vaccinations. Read more below. CDC Recommends the First Updated COVID-19 Booster. The CDC is recommending the COVID-19 boosters from Pfizer-BioNTech...

Key Points: COVID In today’s Recommendation for Industry, we discuss the positive trajectories of COVID and monkeypox. Read more below. COVID-19 may have orphaned 7.5 million kids worldwide. Worldwide, about 10.5 million children may have lost parents or caregivers to...

Key Points: COVID In today’s Recommendation for Industry, we discuss the typical increase of respiratory disease in the fall and how to prepare now. Read more below. Low testosterone in men may raise risk of COVID hospitalization. A study from...

Key Points: COVID In today’s Recommendation for Industry, we discuss the alternating status of monkeypox and Covid. Read more below. FDA authorizes updated COVID boosters from Moderna and Pfizer. The Food and Drug Administration (FDA) announced that it has authorized...

Key Points: COVID In today’s Recommendation for Industry, we discuss 2022-23 U.S. Seasonal Influenza Vaccine Overview. Read more below. Paxlovid, molnupiravir benefit older COVID-19 patients, 2 studies show. One from Israel suggesting that nirmatrelvir-ritonavir (Paxlovid) reduced rates of hospitalization and...

Key Points: COVID In today’s Recommendation for Industry, we discuss the continued trend of Monkeypox and Covid. Read more below. Regular physical activity tied to lower risk of COVID, poor outcomes. At least 150 minutes (2.5 hours) of moderate physical...

Key Points: COVID In today’s Recommendation for Industry, we discuss flu season in the Southern Hemisphere. Read more below. Serious adverse events rare after COVID-19 boosters in young kids. Data collected from two vaccine safety surveillance programs in the first...

TAG Expands Assessments to Include Current Communicable Disease Data Key Points: COVID In today’s Recommendation for Industry, we discuss TAG expanding our public health offerings to include focus on other workplace communicable diseases. Read more below. Global COVID-19 cases down...

Key Points: In today’s Recommendation for Industry, we discuss the “why” behind testing at Day 6 if you’ve been exposed and testing multiple times for COVID if you have symptoms. Read more below. CDC unveils streamlined COVID-19 guidance. As was...

Key Points: In today’s Recommendation for Industry, we discuss the positive COVID trends we are seeing. Read more below. Study: Pfizer COVID vaccine efficacy wanes 27 days after dose 2 in teens. A new study finds waning Pfizer/BioNTech COVID-19 vaccine protection against...